Assessing Amneal Pharmaceuticals: Insights From 4 Financial Analysts
Assessing Amneal Pharmaceuticals: Insights From 4 Financial Analysts
評估Amneal製藥：來自4位金融分析師的見解
4 analysts have expressed a variety of opinions on Amneal Pharmaceuticals (NASDAQ:AMRX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度中，有4位分析師對Amneal Pharmicals（納斯達克股票代碼：AMRX）表達了各種觀點，從看漲到看跌，提出了各種各樣的觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $7.81, along with a high estimate of $9.00 and a low estimate of $6.25. Marking an increase of 26.17%, the current average surpasses the previous average price target of $6.19.
分析師提供了更深入的見解，確定了12個月的目標股價，平均目標價爲7.81美元，最高估計爲9.00美元，低估值爲6.25美元。當前的平均價格上漲了26.17％，超過了之前的平均目標股價6.19美元。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細明細
The analysis of recent analyst actions sheds...
對分析師最近行...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。